• 1
    Robijn S, Hoppe B, Vervaet BA, D'Haese PC, Verhulst A. Hyperoxaluria: A gut-kidney axis? Kidney Int 2011; 80: 11461158.
  • 2
    Nasr SH, D'Agati VD, Said SM, Stokes MB, Largoza MV, Radhakrishnan J, et al. Oxalate Nephropathy Complicating Roux-en-Y Gastric Bypass: An Underrecognized Cause of Irreversible Renal Failure. Clin J Am Soc Nephrol 2008; 3: 16761683.
  • 3
    Chen CL, Fang HC, Chou KJ, Wang JS, Chung HM. Acute oxalate nephropathy after ingestion of star fruit. Am J Kidney Dis 2001; 37: 418422.
  • 4
    Cartery C, Faguer S, Karras A, et al. Oxalate nephropathy associated with chronic pancreatitis. Clin J Am Soc Nephrol 2011; 6: 18951902.
  • 5
    Lieske JC, Kumar R, Collazo-Clavell ML. Nephrolithiasis after bariatric surgery for obesity. Semin Nephrol 2008; 28: 163173.
  • 6
    Currie A, Chetwood A, Ahmed AR. Bariatric surgery and renal function. Obes Surg 2011; 21: 528539.
  • 7
    Patel BN, Passman CM, Fernandez A, et al. Prevalence of hyperoxaluria after bariatric surgery. J Urol 2009: 181: 161166.
  • 8
    Matlaga BR, Shore AD, Magnuson T, Clark JM, Johns R, Makary MA. Effect of gastric bypass surgery on kidney stone disease. J Urol 2009; 181: 25732577.
  • 9
    Maalouf NM, Tondapu P, Guth ES, Livingston EH, Sakhaee K. Hypocitraturia and hyperoxaluria after Roux-en-Y gastric bypass surgery. J Urology 2010; 183: 10261030,
  • 10
    Wu JN, Craig J, Chamie K, Asplin J, Ali MR, Low RK. Urolithiasis risk factors in the bariatric population undergoing gastric bypass surgery. Surg Obes Relat Dis 2011 Sep 21. [Epub ahead of print]
  • 11
    Kumar R, Lieske JC, Collazo-Clavell ML, et al. Fat malabsorption and increased intestinal oxalate absorption are common after Roux-en-Y gastric bypass surgery. Surgery 2011; 149: 654661.
  • 12
    Froeder L, Arasaki CH, Malheiros CA, Baxmann AC, Heilberg IP. Response to dietary oxalate after bariatric surgery. Clin J Am Soc Nephrol 2012; 7: 20332040.
  • 13
    Penniston KL, Kaplon DM, Gould JC, Nakada SY. Gastric band placement for obesity is not associated with increased urinary risk of urolithiasis compared to bypass. J Urol 2009; 182: 23402346.
  • 14
    Semins MJ, Matlaga BR, Shore AD, et al. The effect of gastric banding on kidney stone disease. Urology 2009; 74: 746749.
  • 15
    Semins MJ, Asplin JR, Steele K, et al. The effect of restrictive bariatric surgery on urinary stone risk factors. Urology 2010; 76: 826829.
  • 16
    Chen T, Godebu E, Horgan S, Mirheydar HS, Sur RL. The effect of restrictive bariatric surgery on urolithiasis. J Endourol 2012 [Epub ahead of print]. doi:10.1089/end.2012.0408. PMID: 23006039
  • 17
    Takata MC, Campos GM, Ciovica R, et al. Laparoscopic bariatric surgery improves candidacy in morbidly obese patients awaiting transplantation. Surg Obes Relat Dis 2008; 4: 159164.
  • 18
    Lentine KL, Axelrod D, Abbott KC. Interpreting body composition in kidney transplantation: weighing candidate selection, prognostication, and interventional strategies to optimize health. Clin J Am Soc Nephrol 2011; 6: 12381240.
  • 19
    Nasr SH, Kashtanova Y, Levchuk V, Markowitz GS. Secondary oxalosis due to excess vitamin C intake. Kidney Int 2006; 70: 1672.
  • 20
    Chai W, Liebman M, Kynast-Gales S, Massey L. Oxalate absorption and endogenous oxalate synthesis from ascorbate in calcium oxalate stone formers and non-stone formers. Am J Kidney Dis 2004; 44: 10601069.
  • 21
    Sidhu H, Hoppe B, Hesse A, et al. Absence of Oxalobacter formigenes in cystic fibrosis patients: A risk factor for hyperoxaluria. Lancet 1998; 352: 10261029.
  • 22
    Lefaucheur C, Nochy D, Amrein C, et al. Renal histopathological lesions after lung transplantation in patients with cystic fibrosis. Am J Transplant 2008; 8: 19011910.
  • 23
    Moutzouris D-A, Skaneli G, Margellos V, Apostolou T, Petraki C, Nikolopoulou N. Oxalate nephropathy in a diabetic patient after gastric by-pass. Clin Nephrol 2011; 75: S16S19.
  • 24
    Rifkin SI. Transplantation for renal failure secondary to enteric hyperoxaluria: A case report. J Med Case Rep 2007; 1: 31.
  • 25
    Worcester EM, Fellner SK, Nakagawa Y, Coe FL. Effect of renal transplantation on serum oxalate and urinary oxalate excretion. Nephron 1994; 67: 414418.
  • 26
    Elgstoen KB, Johnsen LF, Woldseth B, Morkrid L, Hartmann A. Plasma oxalate following kidney transplantation in patients without primary hyperoxaluria. Nephrol Dial Transplant 2010; 25: 23412345.
  • 27
    Marangella M, Petrarulo M, Cosseddu D, Vitale C, Linari F. Oxalate balance studies in patients on hemodialysis for type I primary hyperoxaluria. Am J Kidney Dis 1992; 19: 546553.
  • 28
    Franssen CF. Oxalate clearance by haemodialysis—a comparison of seven dialysers. Nephrol Dial Transplant 2005; 20: 19161921.
  • 29
    Pinheiro HS, Camara NO, Osaki KS, De Moura LA, Pacheco-Silva A. Early presence of calcium oxalate deposition in kidney graft biopsies is associated with poor long-term graft survival. Am J Transplant 2005; 5: 323329.
  • 30
    Bagnasco SM, Mohammed BS, Mani H, et al. Oxalate deposits in biopsies from native and transplanted kidneys, and impact on graft function. Nephrol Dial Transplant 2009; 24: 13191325.
  • 31
    Truong LD, Yakupoglu U, Feig D, et al. Calcium oxalate deposition in renal allografts: Morphologic spectrum and clinical implications. Am J Transplant 2004; 4: 13381344.
  • 32
    Kistler H, Peter J, Thiel G, Brunner FP. Seven-year survival of renal transplant for oxalate nephropathy due to short-bowel syndrome. Nephrol Dial Transplant 1995; 10: 14661469.
  • 33
    Bernhardt WM, Schefold JC, Weichert W, et al. Amelioration of anemia after kidney transplantation in severe secondary oxalosis. Clin Nephrol 2006; 65: 216221.
  • 34
    Lightner AL, Lau J, Obayashi P, Birge K, Melcher ML. Potential nutritional conflicts in bariatric and renal transplant patients. Obes Surg 2011; 21: 19651970.
  • 35
    Goldfarb DS, Heilberg IP. Oxalobacter forminges, lactic acid bacteria, and hyperoxaluria: An update. Nephrol Self-Assessment Prog 2012; 11: 231235.
  • 36
    Hamidian Jahromi A, Roberts IS, Winearls CG, Vaidya A. Acute renal failure secondary to oxalosis in a recipient of a simultaneous kidney-pancreas transplant: Was mycophenolate the cause? Nephrol Dial Transplant 2008; 23: 24092411. PMID: 18400815
  • 37
    Nelson WK, Houghton SG, Milliner DS, Lieske JC, Sarr MG. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: Potentially serious and unappreciated complications of Roux-en-Y gastric bypass. Surg Obes Relat Dis 2005; 1: 481485.
  • 38
    Sinha MK, Collazo-Clavell ML, Rule A, et al. Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery. Kidney Int 2007; 72: 100107.
  • 39
    Asplin JR, Coe FL. Hyperoxaluria in kidney stone formers treated with modern bariatric surgery. J Urol 2007; 177: 565569.
  • 40
    Duffey BG, Pedro RN, Makhlouf A, et al. Roux-en-Y gastric bypass is associated with early increased risk factors for development of calcium oxalate nephrolithiasis. J Am Coll Surg 2008; 206: 11451153.
  • 41
    Duffey BG, Alanee S, Pedro RN, et al. Hyperoxaluria is a long-term consequence of Roux-en-Y Gastric bypass: a 2-year prospective longitudinal study. J Am Coll Surg 2010; 211: 815.
  • 42
    Park AM, Storm DW, Fulmer BR, Still CD, Wood GC, Hartle JE 2nd. A prospective study of risk factors for nephrolithiasis after Roux-en-Y gastric bypass surgery. J Urol 2009; 182: 23342339.
  • 43
    Durrani O, Morrisroe S, Jackman S, Averch T. Analysis of stone disease in morbidly obese patients undergoing gastric bypass surgery. J Endourol 2006; 20: 749752.
  • 44
    Wharton R, D'Agati V, Magun AM, Whitlock R, Kunis CL, Appel GB. Acute deterioration of renal function associated with enteric hyperoxaluria. Clin Nephrol 1990; 34: 116121.
  • 45
    Fakhouri F, Chauveau D, Touam M, Noel L-H, Grunfeld. Crystals from fat. Neph Dial Transplant 2002; 17: 13481350.
  • 46
    Dheda S, Swaminathan R, Musk M, Sinniah R, Lawrence S, Irish A. Acute irreversible oxalate nephropathy in a lung transplant recipient treated successfully with a renal transplant. Nephrology 2012; 17(Suppl 1): 1215.
  • 47
    Cuvelier C, Goffin E, Cosyns JP, Wauthier M, de Strihou CY. Enteric hyperoxaluria: A hidden cause of early renal graft failure in two successive transplants. Spontaneous late graft recovery. Am J Kidney Dis 2002; 40: E3.
  • 48
    Rankin AC, Walsh SB, Summers SA, Owen MP, Mansell MA. Acute oxalate nephropathy causing late renal transplant dysfunction due to enteric hyperoxaluria. Am J Transplant 2008; 8: 17551758.
  • 49
    Capolongo G, Abul-Ezz S, Moe OW, Sakhee K. Subclinical celiac disease and crystal-induced kidney disease following kidney transplant. Am J Kidney Dis 2012; 60: 662667.
  • 50
    Roberts RA, Sketris IS, MacDonald AS, Belitsky P. Renal transplantation in secondary oxalosis. Transplantation 1988; 45: 985986.